Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines

Silvia Mussi; Sara Rezzola; Paola Chiodelli; Alessio Nocentini; Claudiu T. Supuran; Roberto Ronca

doi:10.1080/14756366.2021.2004592

Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines

Silvia Mussi, Sara Rezzola, Paola Chiodelli, Alessio Nocentini, Claudiu T. Supuran, Roberto Ronca

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Lingua originale	English
pagine (da-a)	280-286
Numero di pagine	7
Rivista	Journal of Enzyme Inhibition and Medicinal Chemistry
Volume	37
DOI	https://doi.org/10.1080/14756366.2021.2004592
Stato di pubblicazione	Pubblicato - 2022

Keywords

Carbonic anhydrase inhibitors
SLC-0111
pancreatic cancer
glioblastoma
bladder cancer

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1080/14756366.2021.2004592

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

@article{331570e36394429283db896dcf53a852,

title = "Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines",

keywords = "Carbonic anhydrase inhibitors, SLC-0111, pancreatic cancer, glioblastoma, bladder cancer, Carbonic anhydrase inhibitors, SLC-0111, pancreatic cancer, glioblastoma, bladder cancer",

author = "Silvia Mussi and Sara Rezzola and Paola Chiodelli and Alessio Nocentini and Supuran, {Claudiu T.} and Roberto Ronca",

year = "2022",

doi = "10.1080/14756366.2021.2004592",

language = "English",

volume = "37",

pages = "280--286",

journal = "Journal of Enzyme Inhibition and Medicinal Chemistry",

issn = "1475-6366",

publisher = "Informa Healthcare",

}

Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines. / Mussi, Silvia; Rezzola, Sara; Chiodelli, Paola et al.
In: Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 37, 2022, pag. 280-286.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Antiproliferative effects of sulphonamide carbonic anhydrase inhibitors C18, SLC-0111 and acetazolamide on bladder, glioblastoma and pancreatic cancer cell lines

AU - Mussi, Silvia

AU - Rezzola, Sara

AU - Chiodelli, Paola

AU - Nocentini, Alessio

AU - Supuran, Claudiu T.

AU - Ronca, Roberto

PY - 2022

Y1 - 2022

KW - Carbonic anhydrase inhibitors

KW - SLC-0111

KW - pancreatic cancer

KW - glioblastoma

KW - bladder cancer

KW - Carbonic anhydrase inhibitors

KW - SLC-0111

KW - pancreatic cancer

KW - glioblastoma

KW - bladder cancer

UR - http://hdl.handle.net/10807/227692

U2 - 10.1080/14756366.2021.2004592

DO - 10.1080/14756366.2021.2004592

M3 - Article

SN - 1475-6366

VL - 37

SP - 280

EP - 286

JO - Journal of Enzyme Inhibition and Medicinal Chemistry

JF - Journal of Enzyme Inhibition and Medicinal Chemistry

ER -